Search & Analyze
Popular Searches
Lincoln Pharmaceuticals Ltd.
Healthcare₹584.550.02%
24 Jul, 4:01 PM
CMP₹584.55
Mkt Cap₹1.18K Cr
P/E13.43
P/B1.56
ROE13.02%
52W High₹731.50
52W Low₹439.95
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
13.43
P/B Ratio
1.56
EV/EBITDA
8.78
Price/Sales
1.76
Dividend Yield (%)
0.31
EPS (TTM ₹)
43.88
Book Value (₹)
378.25
ROE (%)
13.02
ROCE (%)
17.55
ROA (%)
10.64
EBITDA Margin (%)
15.55
Net Profit Margin (%)
12.62
Debt/Equity
0.00
Current Ratio
4.00
Interest Coverage
58.99
Asset Turnover
0.84
Working Capital/Sales
1.66
Core EBITDA Growth (%)
-7.71
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 42418.54 | 47212.33 | 51030.88 | 58054.96 | 62323.01 |
| Net Sales | 42418.54 | 47212.33 | 51030.88 | 58054.96 | 62323.01 |
| Total Income | 42984.93 | 48212.1 | 53278.17 | 61497.21 | 64570.72 |
| Total Expenditure | 33700.65 | 37664.27 | 42110.56 | 48063.99 | 52173.68 |
| Operating Profit | 9284.28 | 10547.83 | 11167.61 | 13433.22 | 12397.04 |
| Depreciation | 756.03 | 808.78 | 916.62 | 1062.47 | 1289.9 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 8372.08 | 9593.93 | 10047.98 | 12224.26 | 10918.86 |
| Tax | 2147.07 | 2658.43 | 2758.05 | 2893.77 | 2684.22 |
| Profit After Tax (PAT) | 6225.01 | 6935.5 | 7289.93 | 9330.49 | 8234.64 |
| EPS (₹) | 31.08 | 34.63 | 36.4 | 46.58 | 41.11 |
| Dividend Payout % | 15 | 15 | 15 | 18 | 18 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 2002.97 | 2002.97 | 2002.97 | 2002.97 | 2002.97 |
| Reserves | 34636.26 | 41284.77 | 48244.47 | 57280.62 | 65163.89 |
| Shareholders Funds | 36639.23 | 43287.74 | 50247.44 | 59283.59 | 67166.86 |
| Total Debt | 51.97 | 204.36 | 199.72 | 106.68 | 0 |
| Total Liabilities | 48727.68 | 55457.82 | 63650.58 | 72542.42 | 82187.79 |
| Total Assets | 48727.68 | 55457.82 | 63650.58 | 72542.42 | 82187.79 |
| Book Value / Share | 182.9245 | 216.1178 | 250.8647 | 295.9784 | 335.3363 |
| Assets | 48727.68 | 55457.82 | 63650.58 | 72542.42 | 82187.79 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 6926.95 | 7613.19 | 3926.19 | 6321.66 | 9301.55 |
| Investing Activities | -6422.73 | -7808.02 | -3664.26 | -5734.1 | -7894.74 |
| Financing Activities | -574.53 | -255.61 | -450.13 | -518.04 | -640.15 |
| Net Cash Flow | -70.31 | -450.44 | -188.2 | 69.52 | 766.66 |
LINCOLN
₹584.55
+0.02%